Trials / Completed
CompletedNCT04118270
Shared Decision-Making: AFib 2gether Mobile App
Shared Decision-Making: Implementing the AFib 2getherTM Mobile App
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- University of Massachusetts, Worcester · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Shared Decision-Making: AFib 2gether™ is a research study that focuses on a mobile application developed by Pfizer, Inc with consultation from Dr McManus' called AFib 2gether™. Through this app, patients can determine their risk of stroke due to atrial fibrillation and prioritize questions and concerns for discussion with their cardiology provider.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Afib 2gether TM Mobile Application | The Afib 2gether mobile app determines a patient's stroke risk through a series of questions that the patient will answer in the app. |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2020-06-26
- Completion
- 2020-06-26
- First posted
- 2019-10-08
- Last updated
- 2022-05-02
- Results posted
- 2022-03-31
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04118270. Inclusion in this directory is not an endorsement.